Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section with Val De Marne as a site; removed the separate 'Val De Marne Locations' entry and the 'HHS Vulnerability Disclosure' label from the footer; revision updated to v3.3.3.SummaryDifference0.3%

- Check59 days agoChange Detected- Updated page revision from v3.2.0 to v3.3.2; no changes to study content or information.SummaryDifference0.1%

- Check66 days agoChange DetectedRemoval of the government funding status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedNo significant additions or deletions were detected on the page. The content and layout appear unchanged between the two screenshots.SummaryDifference0.5%

- Check109 days agoChange DetectedAdds a critical operating-status notice and a new software version (v3.2.0), replacing the old v3.1.0 reference and guiding users to official status pages.SummaryDifference4%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.